美康生物：控股子公司取得医疗器械注册证

Core Viewpoint - Meikang Bio (300439) announced that its subsidiary, Jiangxi Meikang Shengde Biotechnology Co., Ltd., has obtained a medical device registration certificate for an in vitro diagnostic reagent, specifically a heparin-binding protein test kit, which can serve as an auxiliary indicator for inflammation [1] Group 1 - The product is named the heparin-binding protein test kit (chemiluminescent immunoassay) [1] - The test kit is designed for the quantitative measurement of heparin-binding protein (HBP) concentration in human plasma [1] - The clinical application of the product is as an auxiliary indicator for inflammation [1]